Tonix Pharmaceuticals Holding Corp. Quarterly Entity Common Stock, Shares Outstanding from Q2 2011 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Tonix Pharmaceuticals Holding Corp. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2011 to Q3 2024.
  • Tonix Pharmaceuticals Holding Corp. Entity Common Stock, Shares Outstanding for the quarter ending November 12, 2024 was 187M shares, a 684% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 187M +163M +684% Nov 12, 2024 10-Q 2024-11-12
Q1 2024 84.5M +22M +35.1% Apr 1, 2024 10-K 2024-04-01
Q3 2023 23.8M -33.7M -58.5% Nov 9, 2023 10-Q 2023-11-09
Q2 2023 17.8M -25.3M -58.8% Aug 9, 2023 10-Q 2023-08-10
Q1 2023 62.5M -471M -88.3% Mar 13, 2023 10-K 2023-03-13
Q3 2022 57.5M -382M -86.9% Nov 4, 2022 10-Q 2022-11-07
Q2 2022 43.1M -314M -88% Aug 8, 2022 10-Q 2022-08-08
Q1 2022 534M +210M +64.8% Mar 14, 2022 10-K 2022-03-14
Q3 2021 440M +283M +181% Nov 5, 2021 10-Q 2021-11-08
Q2 2021 358M +227M +174% Aug 9, 2021 10-Q 2021-08-09
Q1 2021 324M +275M +556% Mar 15, 2021 10-K 2021-03-15
Q3 2020 157M +155M +9840% Nov 6, 2020 10-Q 2020-11-09
Q2 2020 130M +115M +748% Aug 7, 2020 10-Q 2020-08-10
Q1 2020 49.4M +43.3M +710% Mar 23, 2020 10-K 2020-03-24
Q3 2019 1.58M -12.6M -88.9% Nov 8, 2019 10-Q 2019-11-08
Q2 2019 15.4M +5.85M +61.5% Aug 8, 2019 10-Q 2019-08-12
Q1 2019 6.09M -1.74M -22.2% Mar 13, 2019 10-K/A 2019-03-18
Q3 2018 14.2M +6.37M +81.4% Nov 8, 2018 10-Q 2018-11-09
Q2 2018 9.51M +2M +26.7% Aug 9, 2018 10-Q 2018-08-13
Q1 2018 7.83M +345K +4.61% Mar 1, 2018 10-K 2018-03-09
Q3 2017 7.83M -31.4M -80% Nov 3, 2017 10-Q 2017-11-06
Q2 2017 7.51M -18.4M -71% Aug 9, 2017 10-Q 2017-08-11
Q1 2017 7.49M -11.4M -60.3% Apr 13, 2017 10-K 2017-04-13
Q3 2016 39.2M +20.3M +108% Nov 8, 2016 10-Q 2016-11-10
Q2 2016 25.9M +7.03M +37.3% Aug 4, 2016 10-Q 2016-08-05
Q1 2016 18.9M +2.74M +17% Mar 2, 2016 10-K 2016-03-03
Q3 2015 18.8M +8.06M +74.8% Nov 5, 2015 10-Q 2015-11-06
Q2 2015 18.8M +8.24M +77.8% Aug 6, 2015 10-Q 2015-08-07
Q1 2015 16.1M +6.24M +63% Feb 25, 2015 10-K 2015-02-27
Q3 2014 10.8M +5.89M +121% Nov 6, 2014 10-Q 2014-11-07
Q2 2014 10.6M +5.71M +117% Aug 7, 2014 10-Q 2014-08-08
Q1 2014 9.9M -33.3M -77.1% Mar 24, 2014 10-K 2014-03-28
Q3 2013 4.88M -29.4M -85.8% Nov 12, 2013 10-Q 2013-11-13
Q2 2013 4.88M -29.4M -85.8% Aug 14, 2013 10-Q 2013-08-14
Q1 2013 43.2M +8.9M +26% Mar 8, 2013 10-K/A 2013-11-22
Q3 2012 34.3M +28.8M +523% Nov 14, 2012 10-Q 2012-11-14
Q2 2012 34.3M +28.8M +523% Aug 13, 2012 10-Q 2012-08-13
Q1 2012 34.3M Mar 20, 2012 10-K 2012-03-30
Q3 2011 5.5M Sep 30, 2011 10-Q 2011-10-07
Q2 2011 5.5M Jun 30, 2011 10-Q 2011-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.